Cancer-related cognitive impairment (CRCI), depression and quality of life in gynecological cancer patients: a prospective study
- PMID: 33404703
- DOI: 10.1007/s00404-020-05896-6
Cancer-related cognitive impairment (CRCI), depression and quality of life in gynecological cancer patients: a prospective study
Abstract
Purpose: Cancer-related cognitive impairment (CRCI) has been reported in non-central nervous system neoplasms survivors. The purpose of this study was to evaluate the perception of cognitive decrement in patients undergoing surgical and / or medical therapy for gynecological cancers.
Methods: All women diagnosed with primary gynecological cancer and undergoing active medical treatment have been enrolled in a prospective study. Before starting treatment (T1) and 6 months after the end of treatment (T2), patients were interviewed to evaluate the effects of cancer treatment on perceived cognitive function (using FACT-Cog -version 3), on depression (using Beck Depression Inventory-II test) and on quality of life (using EORTC-QLQC-30). Age, education level, marital status, lifestyle, menopausal state at diagnosis, cancer type, cancer FIGO stage, treatment modality was also recorded. The differences between baseline and post-treatment results have been evaluated with Student's t test. The results have been stratified by the menopausal state at diagnosis, type of tumor (endometrial, cervical, ovarian, vulvar) disease stage and type of treatment (chemotherapy or radiotherapy).
Results: Seventy-three patients were included. A significant reduction in perceived cognitive impairments was demonstrated at T2 (CogPCI: 61.35 ± 13.83 vs 55.05 ± 16.56; p < 0.05). On the contrary, a significant improvement was shown in depression state (BDII: 21.14 ± 11.23 vs 12.82 ± 12.33, p < 0.005). The menopausal state at surgery, tumor site, stage and treatment modality seem to influence the variables analyzed.
Conclusion: CRCI is a true risk also in gynecological cancer survivors. The cognitive impairment does not seem to be dependent on depression state after treatment or to a menopausal condition. Assessing cognitive decline in cancer survivorship is essential for ensuring the optimum quality of life and functioning.
Keywords: Cancer-related cognitive impairment; Cancer-related depression; Gynecological cancer; Menopause-related cognitive impairment; Quality of life.
References
-
- Bifulco G, De Rosa N, Tornesello ML et al (2012) Quality of life, lifestyle behavior and employment experience: a comparison between young and midlife survivors of gynecology early stage cancers. Gynecol Oncol 124(3):444–451 - DOI
-
- Zabora J, Brintzenhofeszoc K, Curbow B (2001) The prevalence of psychological distress by cancer site. Psychooncology 10:19–28 - DOI
-
- Chepenik LG, Cornew LA, Farah MJ (2007) The influence of sad mood on cognition. Emotion 7(4):802–811 - DOI
-
- Epperson CN, Sammel MD, Freeman EW (2013) Menopause effects on verbal memory: findings from a longitudinal community cohort. J Clin Endocrinol Metab 98:3829–3838 - DOI
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
